CD38 in Advanced Prostate Cancers

CD39 Regulation and Functions in T Cells

Eleonora Timperi
Vincenzo Barnaba

July 2021

CD39 is an enzyme which is responsible, together with CD73, for a cascade converting adenosine triph...

Research Article Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity

Nathalie Bonnefoy
Caroline Laheurte
Emilie Laprevotte
Elisa Funck-brentano
Patrice Hemon
Laurent Gros
Nicole Bec
Christian Larroque
Gilles Alberici

October 2016

The ectonucleotidases CD39 and CD73 hydrolyze extracellular adenosine triphosphate (ATP) and adenosi...

Erythrocyte CD38 as a prognostic marker in cancer.

Tuerker-Sener, Leyla
Bermek, Engin
Albeniz, Işıl
Yalçıntepe, Leman
Demir, Ozlem
Nurten, Rüstem

January 2007

Background: Surface antigen CD38 which is a multifunctional protein with enzymatic and receptorial p...

CD38 in Advanced Prostate Cancers

Guo, C.
Crespo, M.
Gurel, B.
Dolling, D.
Rekowski, J.
Sharp, A.
Petremolo, A.
Sumanasuriya, S.
Rodrigues, D.N.
Ferreira, A.
Pereira, R.
Figueiredo, I.
Mehra, N.
Lambros, M.B.
Neeb, A.
Gil, V.
Seed, G.
Terstappen, L.
Alimonti, A.
Drake, C.G.
Yuan, W.
Bono, J.S. de

January 2021

BACKGROUND: CD38, a druggable ectoenzyme, is involved in the generation of adenosine, which is impli...

CD38 in Advanced Prostate Cancers.

Guo, Christina
Crespo, Mateus
Gurel, Bora
Dolling, David
Rekowski, Jan
Sharp, Adam
Petremolo, Antonella
Sumanasuriya, Semini
Rodrigues, Daniel N
Ferreira, Ana
Pereira, Rita
Figueiredo, Ines
Mehra, Niven
Lambros, Maryou B K
Neeb, Antje
Gil, Veronica
Seed, George
Terstappen, Leon
Alimonti, Andrea
Drake, Charles G
Yuan, Wei
de Bono, Johann S

June 2021

BACKGROUND CD38, a druggable ectoenzyme, is involved in the generation of adenosine, which is imp...

CD38 and Regulation of the Immune Response Cells in Cancer

Sanyog Dwivedi
Erika P. Rendón-Huerta
Vianney Ortiz-Navarrete
Luis F. Montaño

January 2021

Cancer is a leading cause of death worldwide. Understanding the functional mechanisms associated wit...

Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity

Bastid, Jérémy
Regairaz, Anne
Bonnefoy, Nathalie
Dejou, Cécile
Giustiniani, Jérôme
Laheurte, Caroline
Cochaud, Stéphanie
Laprevotte, Emilie
Funck-Brentano, Elisa
Hemon, Patrice
Gros, Laurent
Bec, Nicole
Larroque, Christian
Alberici, Gilles
Bensussan, Armand
Eliaou, Jean-François

March 2015

International audienceThe ectonucleotidases CD39 and CD73 hydrolyze extracellular adenosine triphosp...

CD38 is methylated in prostate cancer and regulates extracellular NAD+

Jack Mottahedeh
Michael C. Haffner
Tristan R. Grogan
Takao Hashimoto
Preston D. Crowell
Himisha Beltran
Andrea Sboner
Rohan Bareja
David Esopi
William B. Isaacs
Srinivasan Yegnasubramanian
Matthew B. Rettig
David A. Elashoff
Elizabeth A. Platz
Angelo M. De Marzo
Michael A. Teitell
Andrew S. Goldstein

September 2018

Abstract Background Cancer cell metabolism requires sustained pools of intracellular nicotinamide ad...

CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes

Parodi, Alessia
Battaglia, Florinda
Kalli, Francesca
Ferrera, Francesca
Conteduca, Giuseppina
Tardito, Samuele
Stringara, Silvia
Ivaldi, F
Negrini, Simone
Borgonovo, Giacomo
Simonato, Alchiede
Traverso, Paolo
Carmignani, Giorgio
Fenoglio, Daniela
Filaci, Gilberto

January 2013

CD39 is an ectoenzyme, present on different immune cell subsets, which mediates immunosuppressive fu...

CD38 is methylated in prostate cancer and regulates extracellular NAD.

Mottahedeh, Jack
Haffner, Michael C
Grogan, Tristan R
Hashimoto, Takao
Crowell, Preston D
Beltran, Himisha
Sboner, Andrea
Bareja, Rohan
Esopi, David
Isaacs, William B
Yegnasubramanian, Srinivasan
Rettig, Matthew B
Elashoff, David A
Platz, Elizabeth A
De Marzo, Angelo M
Teitell, Michael A
Goldstein, Andrew S

January 2018

BackgroundCancer cell metabolism requires sustained pools of intracellular nicotinamide adenine dinu...

The intrinsic role and mechanism of tumor expressed-CD38 on lung adenocarcinoma progression

Long Gao
Yuan Liu
Xiaohong Du
Sai Ma
Minmin Ge
Haijun Tang
Chenfeng Han
Xin Zhao
Yanbin Liu
Yun Shao
Zhao Wu
Lianjun Zhang
Fang Meng
F. Xiao-Feng Qin

July 2021

Abstract It has been recently reported that CD38 expressed on tumor cells of multiple murine and hum...

CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes.

Conteduca, Giuseppina

January 2013

CD39 is an ectoenzyme, present on different immune cell subsets, which mediates immunosuppressive fu...

Low CD38 Identifies Progenitor-like Inflammation-Associated Luminal Cells that Can Initiate Human Prostate Cancer and Predict Poor Outcome.

Liu, Xian
Grogan, Tristan R
Hieronymus, Haley
Hashimoto, Takao
Mottahedeh, Jack
Cheng, Donghui
Zhang, Lijun
Huang, Kevin
Stoyanova, Tanya
Park, Jung Wook
Shkhyan, Ruzanna O
Nowroozizadeh, Behdokht
Rettig, Matthew B
Sawyers, Charles L
Elashoff, David
Horvath, Steve
Huang, Jiaoti
Witte, Owen N
Goldstein, Andrew S

December 2016

Inflammation is a risk factor for prostate cancer, but the mechanisms by which inflammation increase...

Targeting CD39 in cancer

Moesta, Achim K.
Li, Xian-Yang
Smyth, Mark J.

July 2020

The ATP–adenosine pathway functions as a key modulator of innate and adaptive immunity within the tu...

Targeting CD39 in cancer reveals an extracellular ATP- and inflammasome-driven tumor immunity

Li, Xian-Yang
Moesta, Achim K.
Xiao, Christos
Nakamura, Kyohei
Casey, Mika
Zhang, Haiyan
Madore, Jason
Lepletier, Ailin
Aguilera, Amelia Roman
Sundarrajan, Ashmitha
Jacoberger-Foissac, Celia
Wong, Clifford
Dela Cruz, Tracy
Welch, Megan
Lerner, Alana G.
Spatola, Bradley N.
Soros, Vanessa B.
Corbin, John
Anderson, Ana C.
Effern, Maike
Hölzel, Michael
Robson, Simon C.
Johnston, Rebecca L.
Waddell, Nicola
Smith, Corey
Bald, Tobias
Geetha, Nishamol
Beers, Courtney
Teng, Michele W L
Smyth, Mark J.

December 2019

We explored the mechanism of action of CD39 antibodies that inhibit ectoenzyme CD39 conversion of ex...

CD39 Regulation and Functions in T Cells

Eleonora Timperi
Vincenzo Barnaba

July 2021

CD39 is an enzyme which is responsible, together with CD73, for a cascade converting adenosine triph...

Research Article Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity

Nathalie Bonnefoy
Caroline Laheurte
Emilie Laprevotte
Elisa Funck-brentano
Patrice Hemon
Laurent Gros
Nicole Bec
Christian Larroque
Gilles Alberici

October 2016

The ectonucleotidases CD39 and CD73 hydrolyze extracellular adenosine triphosphate (ATP) and adenosi...

Erythrocyte CD38 as a prognostic marker in cancer.

Tuerker-Sener, Leyla
Bermek, Engin
Albeniz, Işıl
Yalçıntepe, Leman
Demir, Ozlem
Nurten, Rüstem

January 2007

Background: Surface antigen CD38 which is a multifunctional protein with enzymatic and receptorial p...

CD38 in Advanced Prostate Cancers

Guo, C.
Crespo, M.
Gurel, B.
Dolling, D.
Rekowski, J.
Sharp, A.
Petremolo, A.
Sumanasuriya, S.
Rodrigues, D.N.
Ferreira, A.
Pereira, R.
Figueiredo, I.
Mehra, N.
Lambros, M.B.
Neeb, A.
Gil, V.
Seed, G.
Terstappen, L.
Alimonti, A.
Drake, C.G.
Yuan, W.
Bono, J.S. de

January 2021

BACKGROUND: CD38, a druggable ectoenzyme, is involved in the generation of adenosine, which is impli...

CD38 in Advanced Prostate Cancers.

Guo, Christina
Crespo, Mateus
Gurel, Bora
Dolling, David
Rekowski, Jan
Sharp, Adam
Petremolo, Antonella
Sumanasuriya, Semini
Rodrigues, Daniel N
Ferreira, Ana
Pereira, Rita
Figueiredo, Ines
Mehra, Niven
Lambros, Maryou B K
Neeb, Antje
Gil, Veronica
Seed, George
Terstappen, Leon
Alimonti, Andrea
Drake, Charles G
Yuan, Wei
de Bono, Johann S

June 2021

BACKGROUND CD38, a druggable ectoenzyme, is involved in the generation of adenosine, which is imp...

CD38 and Regulation of the Immune Response Cells in Cancer

Sanyog Dwivedi
Erika P. Rendón-Huerta
Vianney Ortiz-Navarrete
Luis F. Montaño

January 2021

Cancer is a leading cause of death worldwide. Understanding the functional mechanisms associated wit...

Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity

Bastid, Jérémy
Regairaz, Anne
Bonnefoy, Nathalie
Dejou, Cécile
Giustiniani, Jérôme
Laheurte, Caroline
Cochaud, Stéphanie
Laprevotte, Emilie
Funck-Brentano, Elisa
Hemon, Patrice
Gros, Laurent
Bec, Nicole
Larroque, Christian
Alberici, Gilles
Bensussan, Armand
Eliaou, Jean-François

March 2015

International audienceThe ectonucleotidases CD39 and CD73 hydrolyze extracellular adenosine triphosp...

CD38 is methylated in prostate cancer and regulates extracellular NAD+

Jack Mottahedeh
Michael C. Haffner
Tristan R. Grogan
Takao Hashimoto
Preston D. Crowell
Himisha Beltran
Andrea Sboner
Rohan Bareja
David Esopi
William B. Isaacs
Srinivasan Yegnasubramanian
Matthew B. Rettig
David A. Elashoff
Elizabeth A. Platz
Angelo M. De Marzo
Michael A. Teitell
Andrew S. Goldstein

September 2018

Abstract Background Cancer cell metabolism requires sustained pools of intracellular nicotinamide ad...

CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes

Parodi, Alessia
Battaglia, Florinda
Kalli, Francesca
Ferrera, Francesca
Conteduca, Giuseppina
Tardito, Samuele
Stringara, Silvia
Ivaldi, F
Negrini, Simone
Borgonovo, Giacomo
Simonato, Alchiede
Traverso, Paolo
Carmignani, Giorgio
Fenoglio, Daniela
Filaci, Gilberto

January 2013

CD39 is an ectoenzyme, present on different immune cell subsets, which mediates immunosuppressive fu...

CD38 is methylated in prostate cancer and regulates extracellular NAD.

Mottahedeh, Jack
Haffner, Michael C
Grogan, Tristan R
Hashimoto, Takao
Crowell, Preston D
Beltran, Himisha
Sboner, Andrea
Bareja, Rohan
Esopi, David
Isaacs, William B
Yegnasubramanian, Srinivasan
Rettig, Matthew B
Elashoff, David A
Platz, Elizabeth A
De Marzo, Angelo M
Teitell, Michael A
Goldstein, Andrew S

January 2018

BackgroundCancer cell metabolism requires sustained pools of intracellular nicotinamide adenine dinu...

The intrinsic role and mechanism of tumor expressed-CD38 on lung adenocarcinoma progression

Long Gao
Yuan Liu
Xiaohong Du
Sai Ma
Minmin Ge
Haijun Tang
Chenfeng Han
Xin Zhao
Yanbin Liu
Yun Shao
Zhao Wu
Lianjun Zhang
Fang Meng
F. Xiao-Feng Qin

July 2021

Abstract It has been recently reported that CD38 expressed on tumor cells of multiple murine and hum...

CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes.

Conteduca, Giuseppina

January 2013

CD39 is an ectoenzyme, present on different immune cell subsets, which mediates immunosuppressive fu...

Low CD38 Identifies Progenitor-like Inflammation-Associated Luminal Cells that Can Initiate Human Prostate Cancer and Predict Poor Outcome.

Liu, Xian
Grogan, Tristan R
Hieronymus, Haley
Hashimoto, Takao
Mottahedeh, Jack
Cheng, Donghui
Zhang, Lijun
Huang, Kevin
Stoyanova, Tanya
Park, Jung Wook
Shkhyan, Ruzanna O
Nowroozizadeh, Behdokht
Rettig, Matthew B
Sawyers, Charles L
Elashoff, David
Horvath, Steve
Huang, Jiaoti
Witte, Owen N
Goldstein, Andrew S

December 2016

Inflammation is a risk factor for prostate cancer, but the mechanisms by which inflammation increase...

Targeting CD39 in cancer

Moesta, Achim K.
Li, Xian-Yang
Smyth, Mark J.

July 2020

The ATP–adenosine pathway functions as a key modulator of innate and adaptive immunity within the tu...

Targeting CD39 in cancer reveals an extracellular ATP- and inflammasome-driven tumor immunity

Li, Xian-Yang
Moesta, Achim K.
Xiao, Christos
Nakamura, Kyohei
Casey, Mika
Zhang, Haiyan
Madore, Jason
Lepletier, Ailin
Aguilera, Amelia Roman
Sundarrajan, Ashmitha
Jacoberger-Foissac, Celia
Wong, Clifford
Dela Cruz, Tracy
Welch, Megan
Lerner, Alana G.
Spatola, Bradley N.
Soros, Vanessa B.
Corbin, John
Anderson, Ana C.
Effern, Maike
Hölzel, Michael
Robson, Simon C.
Johnston, Rebecca L.
Waddell, Nicola
Smith, Corey
Bald, Tobias
Geetha, Nishamol
Beers, Courtney
Teng, Michele W L
Smyth, Mark J.

December 2019

We explored the mechanism of action of CD39 antibodies that inhibit ectoenzyme CD39 conversion of ex...

CD39 Regulation and Functions in T Cells

Eleonora Timperi
Vincenzo Barnaba

July 2021

CD39 is an enzyme which is responsible, together with CD73, for a cascade converting adenosine triph...

Research Article Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity

Nathalie Bonnefoy
Caroline Laheurte
Emilie Laprevotte
Elisa Funck-brentano
Patrice Hemon
Laurent Gros
Nicole Bec
Christian Larroque
Gilles Alberici

October 2016

The ectonucleotidases CD39 and CD73 hydrolyze extracellular adenosine triphosphate (ATP) and adenosi...

Erythrocyte CD38 as a prognostic marker in cancer.

Tuerker-Sener, Leyla
Bermek, Engin
Albeniz, Işıl
Yalçıntepe, Leman
Demir, Ozlem
Nurten, Rüstem

January 2007

Background: Surface antigen CD38 which is a multifunctional protein with enzymatic and receptorial p...

CD38 in Advanced Prostate Cancers

Abstract

Extracted data

CD38 in Advanced Prostate Cancers

Abstract

Extracted data

Related items

Related items